Diagnostics Company Hit With Shareholder Suit Over Stock Drop
NEWARK, N.J. — A diagnostics company that develops proprietary genomic tests and services and certain of its current and former executive officers violated federal securities laws by concealing the company’s business,...To view the full article, register now.
Already a subscriber? Click here to view full article